Esperion Therapeutics Had Cash, Cash Equivalents, and Investment Securities Available-For-Sale Totaled $114.8M at Sept 30 >ESPR
Esperion Therapeutics Had Cash, Cash Equivalents, and Investment Securities Available-For-Sale Totaled $114.8M at Sept 30 >ESPR
截至9月30日，Esperion Therapeutics可供出售的現金、現金等價物和投資證券總額爲1.148億美元 >ESPR
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間